February 9, 2017
Analysis: Granules India Limited
This article provides in-depth fundamental analysis of Granules India Ltd, a Hyderabad-based Indian integrated pharmaceutical manufacturer, which focuses on making active pharmaceutical ingredients (API), pharmaceutical formulation intermediates (PFI) and finished dosages (FD) as primary business activities. In order to benefit the maximum from this article, an
- Portfolio returns of 20.1% against Sensex returns of 11.5%.
- We identified companies, which were later invested by Sanjay Bakshi, Mohnish Pabrai, PE funds, Mutual Funds
- See details of stocks in our portfolio
- Get updates of buy/sell transactions in our portfolio by email
“Peaceful Investing” is the result of my experience of more than a decade in stock markets. It aims to find such stocks, where after investing, an investor may sleep peacefully. If later on, the stock prices increase, then the investor is happy as she is now wealthier. If the stock prices decline, even then the investor is happy as she can now buy more quantity of the selected fundamentally good stocks.
Get FREE 4 e-books with 55 Companies Analysis
Learn fundamental stock analysis by reading case studies in these e-books:
Wonderla Holidays, Caplin Point Laboratories, MRF, TVS Srichakra, Divi’s Lab, Granules India, Finolex Cables, Finolex Industries, Chaman Lal Setia Exports, Ultramarine & Pigments, Balaji Amines, Bharat Rasayan, Maithan Alloys and many more.
Get email updates of our articles
Get email updates of our articles